Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Vaccinium Vitis-idaea Leaf, also known as Lingonberry leaf, is a botanical therapeutic containing arbutin, used primarily in traditional medicine for the management of lower urinary tract symptoms and inflammatory conditions of the renal system.
Name
Vaccinium Vitis-idaea Leaf
Raw Name
VACCINIUM VITIS-IDAEA LEAF
Category
Other
Drug Count
4
Variant Count
4
Last Verified
February 17, 2026
About Vaccinium Vitis-idaea Leaf
Vaccinium Vitis-idaea Leaf, also known as Lingonberry leaf, is a botanical therapeutic containing arbutin, used primarily in traditional medicine for the management of lower urinary tract symptoms and inflammatory conditions of the renal system.
Detailed information about Vaccinium Vitis-idaea Leaf
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Vaccinium Vitis-idaea Leaf.
Vaccinium Vitis-idaea Leaf, commonly known as Lingonberry leaf or Cowberry leaf, is a botanical substance derived from the perennial evergreen shrub Vaccinium vitis-idaea, a member of the Ericaceae family. In the context of clinical pharmacology, these leaves are categorized as a 'herbal medicinal product' or a 'urinary tract antiseptic' due to their high concentration of hydroquinone derivatives, specifically arbutin (hydroquinone-O-beta-D-glucopyranoside). While the plant itself is widely recognized as a food source in Northern Europe and North America, the leaves are utilized for their concentrated secondary metabolites which possess antimicrobial, antioxidant, and anti-inflammatory properties.
From a regulatory perspective, Vaccinium Vitis-idaea Leaf is primarily classified as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA) in the United States. However, in the European Union, the European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) has evaluated its traditional use for the relief of symptoms of minor recurrent lower urinary tract infections (UTIs). It is important to distinguish this botanical from its close relative, Arctostaphylos uva-ursi (Bearberry), which contains higher concentrations of arbutin but also higher levels of potentially irritating tannins. Vaccinium Vitis-idaea Leaf belongs to a class of drugs called botanical urinary antiseptics.
The primary therapeutic mechanism of Vaccinium Vitis-idaea Leaf centers on its arbutin content. When ingested, arbutin is a 'prodrug' that remains stable in the acidic environment of the stomach. Upon reaching the small intestine, it is hydrolyzed by intestinal bacteria and enzymes into hydroquinone and glucose. The hydroquinone is then absorbed and conjugated in the liver to form hydroquinone glucuronides and sulfates. These conjugates are transported through the bloodstream to the kidneys, where they are excreted into the urine.
Once in the bladder, if the urine is sufficiently alkaline (pH above 7.0), these conjugates are hydrolyzed back into free hydroquinone. Free hydroquinone is a potent antimicrobial agent that disrupts the cell membranes of common uropathogens, such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Additionally, the leaf contains high levels of polyphenols and flavonoids (such as quercetin and kaempferol) which exert anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines and reducing oxidative stress within the urothelium (the lining of the urinary tract).
Understanding the pharmacokinetics of Vaccinium Vitis-idaea Leaf is essential for optimizing its clinical efficacy and ensuring patient safety.
While not FDA-approved as a primary treatment for acute infections, Vaccinium Vitis-idaea Leaf is traditionally used for several indications:
Vaccinium Vitis-idaea Leaf is available in several preparations, often standardized to arbutin content:
> Important: Only your healthcare provider can determine if Vaccinium Vitis-idaea Leaf is right for your specific condition. Botanical products can vary significantly in potency and purity.
Standardized dosing for Vaccinium Vitis-idaea Leaf is typically based on the arbutin content to ensure therapeutic levels are reached in the urine. Clinical guidelines from traditional pharmacopeias suggest the following ranges for adults (18 years and older):
Vaccinium Vitis-idaea Leaf is NOT recommended for use in children or adolescents under the age of 18. The safety profile regarding hydroquinone exposure in developing renal and hepatic systems has not been established. There is a theoretical risk of metabolic complications in pediatric populations.
Patients with significant renal impairment (estimated Glomerular Filtration Rate [eGFR] < 30 mL/min/1.73m²) should avoid the use of Vaccinium Vitis-idaea Leaf. Since the active metabolites are cleared by the kidneys, impaired renal function can lead to systemic accumulation of hydroquinone, increasing the risk of toxicity.
Caution is advised in patients with chronic liver disease. While arbutin itself is not hepatotoxic at standard doses, the liver is the primary site for the conjugation of hydroquinone. Impaired conjugation capacity could lead to higher levels of free hydroquinone in the systemic circulation.
Geriatric patients often have age-related declines in renal function. Dosing should start at the lower end of the adult range, and hydration status must be monitored closely to ensure adequate urinary output.
To maximize the efficacy of Vaccinium Vitis-idaea Leaf, specific administration guidelines should be followed:
If a dose is missed, it should be taken as soon as the patient remembers. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to make up for a missed one, as this increases the risk of gastric irritation.
Signs of acute overdose may include:
In the event of a suspected overdose, contact a Poison Control Center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on gastric lavage and maintaining respiratory function.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or extend the duration of treatment without medical guidance.
Because Vaccinium Vitis-idaea Leaf contains high concentrations of tannins (polyphenolic compounds), gastrointestinal side effects are the most frequently reported issues. These include:
These symptoms are typically dose-dependent and subside once the supplement is discontinued.
> Warning: Stop taking Vaccinium Vitis-idaea Leaf and call your doctor immediately if you experience any of these serious symptoms:
Vaccinium Vitis-idaea Leaf is strictly intended for short-term use. Prolonged use (exceeding several weeks or months) carries significant risks:
There are currently no FDA black box warnings for Vaccinium Vitis-idaea Leaf, as it is not an FDA-approved prescription drug. However, European regulatory agencies emphasize that it must not be used for more than one week at a time.
Report any unusual symptoms to your healthcare provider. Monitoring for signs of systemic toxicity is essential if the product is used repeatedly.
Vaccinium Vitis-idaea Leaf should only be used as a temporary measure for mild urinary discomfort. It is not a substitute for conventional antibiotic therapy in the case of a systemic or severe infection. Patients should be aware that self-treating a urinary tract infection (UTI) can lead to the infection spreading to the kidneys, a condition known as pyelonephritis, which can be life-threatening.
No FDA black box warnings for Vaccinium Vitis-idaea Leaf. It is regulated as a dietary supplement in the U.S.
For patients who use Vaccinium Vitis-idaea Leaf periodically for recurrent symptoms, the following monitoring is recommended:
Vaccinium Vitis-idaea Leaf generally does not interfere with the ability to drive or operate heavy machinery. However, if a patient experiences dizziness or lightheadedness as a side effect, they should refrain from these activities until the symptoms resolve.
There is no known direct interaction between Vaccinium Vitis-idaea Leaf and alcohol. However, alcohol is a bladder irritant and can dehydrate the body, potentially worsening the symptoms of a UTI and making it harder for the botanical to work effectively. It is best to avoid alcohol during treatment.
There is no evidence of a withdrawal syndrome or a need for tapering when stopping Vaccinium Vitis-idaea Leaf. However, if symptoms return immediately after discontinuation, it indicates that the underlying infection was not fully resolved, and conventional medical treatment is required.
> Important: Discuss all your medical conditions, especially any history of kidney stones or liver disease, with your healthcare provider before starting Vaccinium Vitis-idaea Leaf.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers and vitamins.
Vaccinium Vitis-idaea Leaf must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician:
Patients who are allergic to Uva Ursi (Arctostaphylos uva-ursi) are highly likely to be allergic to Vaccinium Vitis-idaea Leaf, as they share many of the same chemical constituents. There may also be cross-sensitivity with other Vaccinium species, such as Bilberry or Blueberry, though this is less common.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of allergic reactions to berries or herbal teas, before prescribing Vaccinium Vitis-idaea Leaf.
Vaccinium Vitis-idaea Leaf is classified as Category X in the context of herbal safety during pregnancy. The active metabolite, hydroquinone, has been associated with potential mutagenic activity. While human data is sparse, the precautionary principle applies: the risk of potential fetal harm far outweighs any benefit for treating a minor urinary tract infection. Pregnant women with UTI symptoms must seek conventional medical care, as untreated UTIs can lead to preterm labor.
It is not recommended to use Vaccinium Vitis-idaea Leaf while breastfeeding. There is no definitive data on the exact concentration of hydroquinone that enters human milk, but given the compound's potential toxicity, nursing should be avoided if the mother must take this botanical. If used, the mother should consider 'pump and dump' for the duration of treatment plus 24 hours, or use an alternative treatment.
Safety and effectiveness in the pediatric population have not been established. Use in children is contraindicated due to the risk of hydroquinone toxicity and the lack of clinical trials. Parents should consult a pediatrician for appropriate antibiotic therapy for childhood UTIs.
Older adults may be at increased risk for gastrointestinal side effects and renal strain. Because renal function naturally declines with age, the clearance of hydroquinone conjugates may be slower. Geriatric patients should be monitored for signs of confusion or dehydration. It is crucial to ensure that the elderly patient is not taking other medications that acidify the urine, which is common in polypharmacy scenarios.
In patients with moderate renal impairment (Stage 3 CKD), the dose should be reduced, and the duration of use should be strictly limited to 3-5 days. In Stage 4 or 5 CKD, the product is contraindicated. Accumulation of hydroquinone can lead to systemic oxidative stress and further damage to the nephrons.
Patients with Child-Pugh Class B or C hepatic impairment should avoid Vaccinium Vitis-idaea Leaf. The liver's reduced ability to conjugate hydroquinone with sulfate or glucuronide can lead to higher levels of free hydroquinone in the blood, which is toxic to various tissues.
> Important: Special populations require individualized medical assessment. Never self-administer botanical drugs if you are pregnant, nursing, or have chronic organ disease.
The pharmacological activity of Vaccinium Vitis-idaea Leaf is primarily attributed to arbutin. Arbutin is a glycosylated hydroquinone. Upon oral ingestion, arbutin is hydrolyzed by the enzyme beta-glucosidase (produced by intestinal bacteria) into free hydroquinone. Hydroquinone is then absorbed and conjugated in the liver. Once excreted into the urine, the conjugates are hydrolyzed back into free hydroquinone, provided the urine is alkaline. Free hydroquinone acts as a direct antimicrobial by inhibiting bacterial enzymes and disrupting cell wall integrity. Additionally, the leaf's tannins provide an astringent effect, while flavonoids like quercetin inhibit the NF-kB pathway, reducing urothelial inflammation.
The onset of antimicrobial action typically occurs within 3 to 4 hours of the first dose, as the metabolites reach the bladder. The duration of effect per dose is approximately 6 to 8 hours. Tolerance does not typically develop with short-term use, but the effectiveness is strictly dependent on urinary pH. If the urine remains acidic (pH < 7), the pharmacodynamic effect is virtually neutralized.
| Parameter | Value |
|---|---|
| Bioavailability | 67% - 90% (as Arbutin) |
| Protein Binding | < 10% |
| Half-life | 4 - 6 hours |
| Tmax | 1 - 2 hours |
| Metabolism | Gut hydrolysis; Hepatic conjugation (Glucuronidation) |
| Excretion | Renal (75% - 80%) |
Vaccinium Vitis-idaea Leaf is classified as a Botanical Urinary Antiseptic. It is chemically related to other arbutin-containing plants such as Arctostaphylos uva-ursi (Bearberry) and Pyrus communis (Pear) leaves.
Common questions about Vaccinium Vitis-idaea Leaf
Vaccinium Vitis-idaea Leaf, commonly known as Lingonberry leaf, is primarily used in traditional medicine to treat symptoms of mild, recurrent urinary tract infections (UTIs) such as bladder pressure and burning during urination. The leaf contains a compound called arbutin, which the body converts into a natural antiseptic that works within the urinary tract. It is also used for its mild diuretic properties to help flush the kidneys and bladder. However, it is not considered a replacement for standard antibiotics in the case of a severe or acute infection. Healthcare providers typically recommend it only for short-term relief of minor symptoms. Always consult a doctor to ensure your symptoms are not caused by a more serious condition.
The most common side effects associated with Vaccinium Vitis-idaea Leaf are gastrointestinal in nature, including nausea, stomach pain, and occasionally vomiting. These symptoms are largely due to the high concentration of tannins in the leaves, which can irritate the lining of the stomach. Some people may also notice that their urine takes on a greenish-brown tint, which is a harmless side effect of the active ingredients being excreted. Mild allergic reactions like skin itching or a rash can occur in sensitive individuals. Because of the risk of stomach upset, it is often recommended to take the supplement with food. If you experience severe abdominal pain or persistent vomiting, you should stop taking it and contact your healthcare provider.
While there is no known direct chemical interaction between alcohol and Vaccinium Vitis-idaea Leaf, it is generally advised to avoid alcohol during treatment. Alcohol can irritate the bladder and act as a diuretic, which may worsen the symptoms of a urinary tract infection that you are trying to treat. Furthermore, alcohol can contribute to dehydration, which may reduce the effectiveness of the botanical's antiseptic properties. Staying well-hydrated with water is essential for the product to work correctly. Alcohol may also increase the likelihood of experiencing nausea, a common side effect of the leaf extract. For the best results and to support your recovery, it is recommended to abstain from alcohol until your symptoms have fully resolved.
No, Vaccinium Vitis-idaea Leaf is not considered safe for use during pregnancy. The active component, arbutin, is converted by the body into hydroquinone, a substance that may have toxic or mutagenic effects on developing cells. There is a lack of rigorous clinical studies confirming its safety in pregnant women, and the potential risks to the fetus are significant. Additionally, treating a urinary tract infection with herbal remedies alone during pregnancy is dangerous, as untreated UTIs can lead to serious complications like kidney infections or preterm labor. If you are pregnant and suspect you have a UTI, you must contact your OB/GYN or healthcare provider immediately for FDA-approved treatments. Breastfeeding mothers should also avoid this product.
The effects of Vaccinium Vitis-idaea Leaf typically begin within a few hours of the first dose as the active metabolites reach the bladder. Most patients report a reduction in the burning sensation and urinary urgency within 24 to 48 hours of starting treatment. However, the speed of action depends heavily on the alkalinity of the urine; if the urine is too acidic, the product may not work at all. To ensure it works effectively, many practitioners suggest maintaining an alkaline diet or taking a small amount of baking soda during the treatment period. If you do not see any improvement in your symptoms after 48 hours, you should consult a doctor. It is important to remember that this product is only intended for short-term use, usually no more than seven days.
Yes, you can stop taking Vaccinium Vitis-idaea Leaf suddenly, as it does not cause physical dependence or withdrawal symptoms. In fact, this product is designed for short-term use only and should not be taken for more than one week at a time. If you have completed a five-to-seven-day course and your symptoms have resolved, you can simply stop. However, if you stop taking it and your symptoms immediately return or worsen, it suggests that the underlying infection was not fully cleared. In such cases, you should not start another course of the leaf extract but instead see a healthcare professional for a formal diagnosis and potential antibiotic prescription. Long-term use of this botanical is discouraged due to the potential for hydroquinone toxicity.
If you miss a dose of Vaccinium Vitis-idaea Leaf, you should take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. You should never take two doses at once to make up for a missed one, as this can increase the risk of stomach irritation and nausea. Maintaining a consistent level of the herb in your system helps ensure that the antiseptic metabolites are consistently present in your urine. To help you remember, try taking your doses at the same time each day, such as with breakfast and dinner. If you miss several doses in a row, the effectiveness of the treatment may be reduced, and you should monitor your symptoms closely.
There is no clinical evidence to suggest that Vaccinium Vitis-idaea Leaf causes weight gain. The product is used for short durations (up to seven days) and does not contain significant calories or ingredients that affect metabolism, fat storage, or appetite in a way that would lead to weight changes. If you notice sudden weight gain or swelling (edema) while taking this product, it is more likely related to an underlying health issue, such as kidney dysfunction or a reaction to other medications, rather than the lingonberry leaf itself. Always report significant or unexplained weight changes to your doctor. Because it is used for urinary issues, any changes in fluid retention should be monitored closely.
Vaccinium Vitis-idaea Leaf can interact with several types of medications, so caution is necessary. Most importantly, it should not be taken with medications that acidify the urine, such as high-dose Vitamin C or certain diuretics, because acidic urine prevents the herb from working. It may also have additive effects with prescription diuretics, potentially leading to dehydration. There is a theoretical concern when taking it with medications that affect the liver, as both require hepatic processing. Always provide your healthcare provider with a full list of your current medications, including supplements and over-the-counter drugs, before starting this botanical. They can help you determine if there are any contraindications specific to your health profile.
Vaccinium Vitis-idaea Leaf is a botanical substance, so it is not 'generic' in the way pharmaceutical drugs are, but it is widely available from many different supplement manufacturers. You can find it sold under various names, such as Lingonberry Leaf, Cowberry Leaf, or as part of 'Urinary Support' complexes. When shopping for this product, it is important to look for a 'standardized extract' that lists the specific amount of arbutin, as this is the active component. Because dietary supplements are not regulated as strictly as prescription drugs by the FDA, choosing a reputable brand that undergoes third-party testing for purity and potency is highly recommended. Your pharmacist or a qualified herbalist can often help you select a high-quality product.